Skip to main content
Canna~Fangled Abstracts

Exploring Genetic Diversity for High CBD Content in Cannabis Accessions in Tropical and Subtropical Regions of India

By September 25, 2024October 2nd, 2024No Comments


doi: 10.1007/s10528-024-10914-2.

Online ahead of print.
Affiliations 

Abstract

Cannabis, also known as marijuana or hemp, has been utilized since ancient times for industrial, religious, recreational, and medical uses. However, regardless of the intended use, there are legal requirements for quantitative testing of cannabinoids across the supply chains. This investigation aimed to evaluate the genetic diversity of 54 Cannabis samples collected from tropical and subtropical regions in India. The research found a high genotypic coefficient of variation (GCV), phenotypic coefficient of variation (PCV), heritability, and genetic advance for total cannabidiol (CBD) content. The genotypic and phenotypic correlation among the morpho-chemical characters revealed strong positive correlations among most characters. Clustering and Principal component analysis identified three accessions in cluster II (CIM-CS-65, CIM-CS-189 & CIM-CS-64) with high CBD content that could be used for breeding and as sources of high CBD content in Cannabis. CIM-CS-64, with its high CBD content with 0.01%THC content, holds potential as a valuable parental line for utilization in hybridization programs and recombinant breeding. Furthermore, in accordance with the NDPC Act of 1985, CIM-CS-64 can be commercialized for medicinal purposes, making it a promising source for the development of medicinal CBD products.

Keywords: Cannabis sativa, Clustering, Genetic variability, High CBD content, PCA

PubMed Disclaimer

References

    1. Andre CM, Hausman JF, Guerriero G (2016) Cannabis sativa: the plant of the thousand and one molecules. Front Plant Sci 7:1–17. https://doi.org/10.3389/fpls.2016.00019 – DOI
    1. Baker PB, Gough TA, Taylor BJ (1982) The physical and chemical features of Cannabis plants grown in the United Kingdom of Great Britain and Northern Ireland from seeds of known origin. Bull Narc 34:27–36 – PubMed
    1. Booth JK, Bohlmann J (2019) Terpenes in Cannabis sativa—From plant genome to humans. Plant Sci 284:67–72. https://doi.org/10.1016/j.plantsci.2019.03.022 – DOI – PubMed
    1. Borrelli F et al (2014) Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid. Carcinogenesis 35:2787–97. https://doi.org/10.1093/carcin/bgu205 – DOI – PubMed
    1. Burton GN, Devane EM (1953) Estimating heritability in fall fescue (Festuca arundiancea L.) from replicated clonal materials. Agro J 45:478–481 – DOI

LinkOut – more resources


Leave a Reply